We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (383)
- Scheduling (national classification system) (164)
- Safety monitoring and information (26)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Medicinal cannabis hub (6)
- Clinical trials (5)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
758 result(s) found, displaying 576 to 600
-
Meeting statementsACM 7 meeting statement has been published
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Scheduling submissionsPublic submissions on matters referred to the March 2017 scheduling meetings, and received during the pre-meeting and interim decision consultation periods, are now available
-
Meeting statementsACM 5 meeting statement has been published
-
Meeting statementsACM 2 meeting statement has been published
-
Meeting statementsACM 3 meeting statement has been published
-
Meeting statementsACM 4 meeting statement has been published
-
Meeting statementsAdvisory Committee on Medical Devices
-
Scheduling delegates' interim decisions and invitation for further comment: ACCS/ACMS, November 2017
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 5 March 2018 -
Scheduling decisions (final)Scheduling delegates' final decisions: NCEs, January 2017 now published
-
Meeting statementsACV 1 meeting statement has been published
-
Meeting statementsACV 2 meeting statement has been published
-
Corporate reportsThis document reflects the evidence supporting the use of medicinal cannabis in treating chronic pain and the recommendations of the Chronic Pain Working Group
-
Meeting statementsACMD 32 meeting statement has been published
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Scheduling decisions (final)Final decisions and reasons for matters referred to ACCS#20, ACMS #21 (July 2017 meetings) and Joint ACCS-ACMS #15 and #16 (March and July 2017meetings).
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 7 statement
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 8 statement
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 9 statement
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 10 statement
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations